MNKD today
$4.16-$0.03 (-0.72%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bullish
1 hourStrong Bullish
15 minLeaning Bullish
5 minStrong Bearish
Daily trend turns up above $4.55
Key levels
Resistance$4.55
Resistance$4.29
Support$3.90
Support$3.45
Latest news & SEC filings
AnalystRBC Capital Markets raises MannKind Corporation price target
AnalystRBC Capital keeps Sector Perform on MannKind, lifts target to $5
All MNKD news →About MannKind
MannKind is a biopharmaceutical company that develops and commercializes drug-device combination therapies for cardiometabolic and orphan lung diseases. Its commercial products include Afrezza, an inhaled insulin for diabetes; Furoscix, a subcutaneous furosemide formulation for edema tied to cardiac or kidney conditions; and V-Go, a wearable insulin delivery device. It also manufactures Tyvaso DPI, an inhaled treprostinil therapy for pulmonary hypertension, for United Therapeutics, which commercializes the product and pays MannKind royalties. MannKind sells its products in the United States and partners with regional companies in other markets.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
MANNKIND CORP (MNKD)
What Is the Price Target for MNKD?
SEPT Low Target
$4.75
SEPT Mid Target
$9.00
SEPT High Target
$13.00
Analyst Consensus
$9.00
Is MNKD a Buy or Sell Right Now?
Thesis
- •Revenue growing 22.2% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MNKD.
Start Free Trial →Is MNKD Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$9.00
13
Moat Score
NONE
4/9
Piotroski Score
-4.0
Altman Z-Score
What Is Smart Money Doing with MNKD?
Insider Signal
NEUTRAL
1 buys / 3 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Binder Steven B. | director | Sale | 39,051 | $128K | Sep 25, 2026 |
| Consiglio Ronald J | director | Buy | 10,000 | $30K | May 20, 2026 |
| Tross Stuart A | officer | Buy | 33,898 | $100K | May 20, 2026 |
| Marasco Dominic | officer | Buy | 8,474 | $25K | May 20, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MNKD Growth Story
Revenue YoY
22.2%
3yr Revenue CAGR
51.8%
EPS Growth YoY
-80%
FCF Growth YoY
-58.3%
Revenue Trend
STRONG
Dark Pool Trades for MNKD
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MNKD, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:30:10 | $4.16 | 4,951 | $$21K | SELL |
| 21:30:03 | $4.16 | 929,088 | $$3.9M | SELL |
| 21:01:01 | $4.16 | 1,271 | $$5K | BUY |
| 21:00:41 | $4.16 | 22,073 | $$92K | BUY |
| 21:00:41 | $4.16 | 3,603 | $$15K | BUY |
5 dark pool trades shown · $$4.0M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for MNKD
PREVIEWSEPT Investing provides real-time options flow tracking for MNKD, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $4 | Dec 18 | 36 | $$300 | 6 | SWEEP |
| CALL | $4 | Jan 15 | 64 | $$114 | 2 | SWEEP |
| CALL | $4 | Jan 21 | 435 | $$264 | 2 | SWEEP |
| CALL | $4 | Jan 21 | 435 | $$135 | 1 | SWEEP |
| CALL | $4 | Jan 15 | 64 | $$60 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for MANNKIND CORP (MNKD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MNKD — frequently asked questions
What is MNKD stock price today?
MANNKIND CORP (MNKD) is at $4.16, down 0.72% (-$0.03) at the Nov 12, 2026 close.
Why is MNKD stock moving today?
Latest MNKD news — Nov 7, 2026: RBC Capital Markets raises MannKind Corporation price target · Nov 6, 2026: RBC Capital keeps Sector Perform on MannKind, lifts target to $5
What is the MNKD price target?
The average analyst price target for MNKD is $9.00, ranging from $5 to $13, based on 8 analysts.
What do analysts rate MNKD?
Analyst ratings for MNKD: 1 Buy, 10 Hold, 0 Sell — consensus Hold.
Did MNKD beat earnings?
MNKD last reported on Aug 5, 2026: EPS -$0.06 vs -$0.01 expected — a miss of 700.0%.
Does MNKD pay a dividend?
MNKD does not currently pay a dividend.
How much debt does MNKD have?
MANNKIND CORP reported $319M of debt and $53M of cash (Jun 30, 2026).
What are MNKD support and resistance levels?
Support: $3.90, $3.45, $3.01. Resistance: $4.29, $4.55, $5.03.
What are insiders doing with MNKD?
Insider activity: NEUTRAL, 1 buys and 3 sells in the last 90 days.
What is the latest news on MNKD?
Nov 7, 2026: RBC Capital Markets raises MannKind Corporation price target · Nov 6, 2026: RBC Capital keeps Sector Perform on MannKind, lifts target to $5